scholarly journals A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activatingFLT3mutations

2015 ◽  
Vol 169 (5) ◽  
pp. 694-700 ◽  
Author(s):  
Walter Fiedler ◽  
Sabine Kayser ◽  
Maxim Kebenko ◽  
Melanie Janning ◽  
Jürgen Krauter ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Intensive Chemotherapy ◽  
Acute Myeloid

scholarly journals Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

2018 ◽  
Vol 184 (6) ◽  
pp. 1018-1021 ◽  
Author(s):  
Oliver G. Ottmann ◽  
Carsten Müller-Tidow ◽  
Alwin Krämer ◽  
Richard F. Schlenk ◽  
Michael Lübbert ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Dose Escalation ◽  
Acute Myeloid

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

The Lancet ◽  
2010 ◽  
Vol 376 (9757) ◽  
pp. 2000-2008 ◽  
Author(s):  
Utz Krug ◽  
Christoph Röllig ◽  
Anja Koschmieder ◽  
Achim Heinecke ◽  
Maria Cristina Sauerland ◽  
...  
Keyword(s):  
Complete Remission ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Early Death ◽  
Intensive Chemotherapy ◽  
Web Based ◽  
Acute Myeloid

Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia

2009 ◽  
Vol 38 (S47) ◽  
pp. 33-42
Author(s):  
David Machover ◽  
Julio Gastiaburu ◽  
Michel Delgado ◽  
Emma Goldschmidt ◽  
Manuel Benavides ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document